Clinical Prognostic Factors in 86 Chinese Patients with Primary Myelodysplastic Syndromes and Trisomy 8: A Single Institution Experience

키워드

참고문헌 (36)

1. Greenberg PL, "Myelodysplastic syndromes", Hematology Am Soc Hematol Educ Program, 2002, pp.136~161 (2002)
2. Nimer SD, "Myelodysplastic syndromes", Blood, 111, pp.4841~4851 (2008)
3. Nolte F, "Myelodysplastic syndromes: molecular pathogenesis and genomic changes", Ann Hematol, 87, pp.777~795 (2008)
4. Mufti GJ, "Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts", Haematologica, 93, pp.1712~1717 (2008)
5. Solé F, "Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes", Haematologica, 90, pp.1168~1178 (2005)
6. Bernasconi P, "World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes", Br J Haematol, 137, pp.193~205 (2007)
7. Malcovati L, "Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes", J Clin Oncol, 25, pp.3503~3510 (2007)
8. Greenberg PL, "Revised international prognostic scoring system for myelodysplastic syndromes", Blood, 120, pp.2454~2465 (2012)
9. Germing U, "Prognostic scoring systems in MDS", Leuk Res, 36, pp.1463~1469 (2012)
10. Greenberg P, "International scoring system for evaluating prognosis in myelodysplastic syndromes", Blood, 89, pp.2079~2088 (1997)
11. Paulsson K, "Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes", Pathol Biol (Paris), 55, pp.37~48 (2007)
12. Irons RD, "Prevalence of MDS subtypes in Shanghai, China: a comparison of the World Health Organization and French American British classifications", Leuk Res, 30, pp.769~775 (2006)
13. Qu S, "Impacts of cytogenetic categories in the Revised International Prognostic Scoring System on the prognosis of primary myelodysplastic syndromes:results of a single-center study", Leuk Lymphoma, 53, pp.940~946 (2012)
14. Xiao Y, "Trisomy 8 is the most frequent cytogenetic abnormality in de novo myelodysplastic syndrome in China", Onkologie, 35, pp.100~106 (2012)
15. Ma Y, "Prognostic value of trisomy 8 in primary myelodysplastic syndrome", Intern Med J, 40, pp.697~703 (2010)
16. Cazzola M, "Classification and prognostic evaluation of myelodysplastic syndromes", Semin Oncol, 38, pp.627~634 (2011)
17. Sloand EM, "Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome", Blood, 106, pp.841~851 (2005)
18. Olnes MJ, "Directed therapy for patients with myelodysplastic syndromes(MDS) by suppression of cyclin D1 with ON 01910.Na", Leuk Res, 36, pp.982~989 (2012)
19. Malcovati L, "Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)", Haematologica, 96, pp.1433~1440 (2011)
20. Gonzalez Garcia JR, "Use of the International System for Human Cytogenetic Nomenclature (ISCN)", Blood, 108, pp.3952~3953 (2006)
21. Chun K, "Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: An International Working Group on MDS Cytogenetics Study", Leuk Res, 34, pp.160~165 (2010)
22. Vardiman JW, "The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia:rationale and important changes", Blood, 114, pp.937~951 (2009)
23. Wellner JA, "On an exponential bound for the Kaplan-Meier estimator", wLifetime Data Anal, 13, pp.481~496 (2007)
24. Gill RD, "Multistate life-tables and regression models", Math Popul Stud, 3, pp.259~276 (1992)
25. Pozdnyakova O, "Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities", Cancer, 113, pp.3331~3340 (2008)
26. Matsuda A, "Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes", Blood, 106, pp.2633~2640 (2005)
27. Lee JJ, "Comparisons of prognostic scoring systems for myelodysplastic syndromes:a Korean multicenter study", Leuk Res, 23, pp.425~432 (1999)
28. Kuendgen A, "Differences in epidemiolo-gy of MDS between Western and Eastern countries: ethnic differences or environmental influence?", Leuk Res, 31, pp.103~104 (2007)
29. Chen B, "Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries", Leukemia, 19, pp.767~775 (2005)
30. Li L, "Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients", Leuk Res, 33, pp.1194~1198 (2009)
31. Al Ameri A, "Significance of thrombocytopenia in myelodysplastic syndromes: associations and prognostic implications", Clin Lymphoma Myeloma Leuk, 11, pp.237~241 (2011)
32. Lee JH, "Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome", Leukemia, 17, pp.305~313 (2003)
33. Pereira A, "Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support", Am J Hematol, 86, pp.245~250 (2011)
34. Saumell S, "Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes", Br J Haematol, 159, pp.311~321 (2012)
35. Haase D, "New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients", Blood, 110, pp.4385~4395 (2007)
36. Schanz J, "Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system", J Clin Oncol, 29, pp.1963~1970 (2011)

관련 논문AI추천